Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 8, 2017Molecular Therapy — Nucleic AcidsOpen Access

CRISPR/Cas9: Transcending the Reality of Genome Editing

View Full Paper
Ask AI
Bookmark
Share

Authors

SCSergiu ChiraIuliu Hațieganu University of Medicine and PharmacyDGDiana GuleiIuliu Hațieganu University of Medicine and PharmacyAHAmin HajitouLondon Cancer

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chira et al. (2017) studied this question.

synapsesocial.com/papers/6a7628c1be276543018c5bd0https://doi.org/10.1016/j.omtn.2017.04.001
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Development of an intein-mediated split–Cas9 system for gene therapy2015 · 389 citations
  2. 2Targeting miR-21 for the Therapy of Pancreatic Cancer2013 · 219 citations
  3. 3A Hybrid Vector System Expands Adeno-associated Viral Vector Packaging Capacity in a Transgene-independent Manner2007 · 164 citations
  4. 4CRISPR library designer (CLD): software for multispecies design of single guide RNA libraries2016 · 97 citations
  5. 5CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in mice2015 · 196 citations